Cholesterol, HDL - Blood (Latest Articles)

Latest indexed articles for 'Cholesterol, HDL - Blood'

Articles 1 to 10 of 200:

Assessing niacin as an atherosclerosis therapeutic agent valuable insights provided by high-resolution vascular magnetic resonance imaging.

Nov 2009
rec_pub_19874993-assessing-niacin-atherosclerosis-therapeutic-agent-valuable-insights.htm

Effects of high-dose modified-release nicotinic acid on atherosclerosis and vascular function: a randomized, placebo-controlled, magnetic resonance imaging study.

Nov 2009 OBJECTIVES: Our aim was to determine the effects of high-dose (2 g) nicotinic acid (NA) on progression of atherosclerosis and measures of vascular function. BACKGROUND: NA raises high-density lipoprotein cholesterol (HDL-C) and reduces low-density ...
rec_pub_19874992-effects-high-dose-modified-release-nicotinic-acid-atherosclerosis.htm

Evaluating the incremental benefits of raising high-density lipoprotein cholesterol levels during lipid therapy after adjustment for the reductions in other blood lipid levels.

24 Oct 2009 BACKGROUND: The role of high-density lipoprotein cholesterol (HDL-C) as a therapeutic target to prevent cardiovascular (CV) events remains unclear. We examined data from the Framingham Offspring Study from 1975 through 2003 to determine whether ...
rec_pub_19858435-evaluating-incremental-benefits-raising-high-density-lipoprotein.htm

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity.

3 Oct 2009 A cluster of risk factors for cardiovascular disease and type 2 diabetes mellitus, which occur together more often than by chance alone, have become known as the metabolic syndrome. The risk factors include raised blood pressure, dyslipidemia ...
rec_pub_19805654-harmonizing-metabolic-syndrome-joint-interim-statement-international.htm

Scavenger receptor class B type I mediates biliary cholesterol secretion independent of ATP-binding cassette transporter g5/g8 in mice.

29 Sep 2009 Scavenger receptor class B type I (SR-BI) mediates selective uptake of cholesterol from high-density lipoprotein (HDL) particles by the liver and influences biliary cholesterol secretion. However, it is not clear, if this effect is direct or ...
rec_pub_19637290-scavenger-receptor-class-b-type-mediates-biliary-cholesterol.htm

Cardiovascular event risk: high-density lipoprotein and paraoxonase.

27 Sep 2009
rec_pub_19778664-cardiovascular-event-risk-high-density-lipoprotein-paraoxonase.htm

Paraoxonase variants relate to 10-year risk in coronary artery disease: impact of a high-density lipoprotein-bound antioxidant in secondary prevention.

27 Sep 2009 OBJECTIVES: We investigated the effects of paraoxonase (PON)-1 variants on long-term clinical outcome in patients with coronary artery disease (CAD). BACKGROUND: PON-1 is a potential therapeutic target to further reduce cardiovascular risk because ...
rec_pub_19778663-paraoxonase-variants-relate-10-year-risk-coronary-artery-disease.htm

Effects of increasing high-density lipoprotein cholesterol and decreasing low-density lipoprotein cholesterol on the incidence of first acute coronary events (from the Air Force/Texas Coronary Atherosclerosis Prevention Study).

13 Sep 2009 Reducing low-density lipoprotein (LDL) cholesterol with statins reduces cardiovascular risk, but the associations between increases in high-density lipoprotein (HDL) cholesterol and cardiovascular risk at different LDL levels have been less well ...
rec_pub_19733719-effects-increasing-high-density-lipoprotein-cholesterol-decreasing.htm

Acute effects of statin therapy on coronary atherosclerosis following an acute coronary syndrome.

13 Sep 2009 No data exist on the acute effects of statin therapy on human coronary atherosclerotic plaques. The objective of our study was to evaluate the early (<2 months) effects of newly initiated statin therapy on coronary atherosclerosis as evaluated by ...
rec_pub_19733706-acute-effects-statin-therapy-coronary-atherosclerosis-following-acute.htm

ApoB versus non-HDL-C: what to do when they disagree.

30 Aug 2009 The high correlation between apolipoprotein B (apoB) and non-high-density lipoprotein cholesterol (non-HDL-C) is the chief argument employed against introducing apoB into clinical practice. However, high correlation does mean that non-HDL-C and apoB ...
rec_pub_19664379-apob-versus-non-hdl-c-disagree.htm

Results: [1-10] [11-20] [21-30] [31-40] [41-50] [51-60] [61-70] [71-80] [81-90] [91-100] [101-110] [111-120] [121-130] [131-140] [141-150] [151-160] [161-170] [171-180] [181-190] [191-200]